EMED (Electromedical Technologies) Beneish M-Score: 0.00 (As of Jun. 28, 2026)


What is Electromedical Technologies Beneish M-Score?

Electromedical Technologies EMED Beneish M-Score is 0.00 as of Jun. 28, 2026.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Electromedical Technologies's Beneish M-Score or its related term are showing as below:

During the past 5 years, the highest Beneish M-Score of Electromedical Technologies was 0.00. The lowest was 0.00. And the median was 0.00.

Electromedical Technologies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Electromedical Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromedical Technologies Beneish M-Score Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
0.00 0.00 -21.86 0.00 0.00

Electromedical Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EMED vs DYNT, SONX, USAQ: Beneish M-Score Comparison

For the Medical Devices subindustry, Electromedical Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Electromedical Technologies Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Electromedical Technologies's Beneish M-Score falls into.


Electromedical Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Electromedical Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was $0.01 Mil.
Revenue was 0.043 + 0.238 + 0.29 + 0.352 = $0.92 Mil.
Gross Profit was 0.031 + 0.173 + 0.217 + 0.271 = $0.69 Mil.
Total Current Assets was $0.31 Mil.
Total Assets was $0.57 Mil.
Property, Plant and Equipment(Net PPE) was $0.26 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.05 Mil.
Selling, General, & Admin. Expense(SGA) was $1.47 Mil.
Total Current Liabilities was $4.36 Mil.
Long-Term Debt & Capital Lease Obligation was $0.21 Mil.
Net Income was -0.725 + 0.231 + -0.836 + -0.349 = $-1.68 Mil.
Non Operating Income was -0.289 + 0.541 + -0.622 + -0.067 = $-0.44 Mil.
Cash Flow from Operations was -0.031 + 0.109 + -0.158 + -0.051 = $-0.13 Mil.
 Total Receivables was $0.01 Mil.
Revenue was 0.324 + 0.295 + 0.379 + 0.423 = $1.42 Mil.
Gross Profit was 0.251 + 0.232 + 0.291 + 0.333 = $1.11 Mil.
Total Current Assets was $0.54 Mil.
Total Assets was $0.85 Mil.
Property, Plant and Equipment(Net PPE) was $0.31 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.02 Mil.
Selling, General, & Admin. Expense(SGA) was $2.41 Mil.
Total Current Liabilities was $3.09 Mil.
Long-Term Debt & Capital Lease Obligation was $0.27 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.007 / 0.923) / (0.009 / 1.421)
=0.007584 / 0.006334
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1.107 / 1.421) / (0.692 / 0.923)
=0.779029 / 0.749729
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (0.305 + 0.263) / 0.569) / (1 - (0.543 + 0.31) / 0.853)
=0.001757 / 0
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.923 / 1.421
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.015 / (0.015 + 0.31)) / (0.052 / (0.052 + 0.263))
=0.046154 / 0.165079
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.466 / 0.923) / (2.413 / 1.421)
=1.588299 / 1.6981
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.214 + 4.356) / 0.569) / ((0.269 + 3.091) / 0.853)
=8.031634 / 3.939039
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-1.679 - -0.437 - -0.131) / 0.569
=-1.952548

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 0.00 mean?
Electromedical Technologies (EMED) has a Beneish M-Score of 0.00 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Electromedical Technologies and its competitors.
Is Electromedical Technologies' Beneish M-Score too high?
Electromedical Technologies' current Beneish M-Score is 0.00.
How does Electromedical Technologies' Beneish M-Score compare to DYNT and SONX?
Electromedical Technologies' Beneish M-Score of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Electromedical Technologies and its competitors. Electromedical Technologies's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromedical Technologies stock overvalued right now?
Electromedical Technologies (EMED) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Electromedical Technologies (EMED), the current Beneish M-Score is 0.00 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Electromedical Technologies Business Description

Address 10105 E. Via Linda, No. 103-300, Scottsdale, AZ, USA, 85258
Electromedical Technologies Inc is a Delaware-based bioelectronics manufacturing company. The company designs, develops, and markets FDA-cleared, non-invasive, and simple-to-use bioelectronics therapy medical devices that serve as drug-free alternatives for pain relief. The company's device provide immediate and long-lasting pain relief across the broadest range of ailments. It focuses on improving globalised wellness for people suffering from various painful conditions.